Baudax Bio, Inc. BXRXQ

—

0.00 0.00 NaN as of 25 Sep

Market cap: —
P/E: 0.0×

Follow BXRXQ

Revenue Champion (5y)

Growth Flags show if company had growth for consecutive years

Overview Business Profile Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions

in millions of $

	Nov 25			Feb 26			May 26			Aug 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership —

Capital & Financial Ratios

Market Cap —

Revenue 1.08

Net Income (7.15)

Free Cash Flow (24.54)

Net Debt 4.87

Current Ratio 0.07

Debt/Equity (0.51)

P/E ratio 0.00

P/S ratio 0.00

P/B ratio 0.00

Past 5Y EPS Growth —

This Y EPS Growth —

Next Y EPS Growth —

Next 5Y EPS Growth —

in millions of $

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

Assets vs Liabilities

	2020	2021	2022	Q'23
Cash	30	16	5	0
Receivables	0	1	0	—
Inventory	3	5	—	—
Other	—	—	—	—
	37	23	6	1

	2020	2021	2022	Q'23
Payables	4	1	4	8
ST’ Debt	1	2	6	5
Other	8	6	9	2
	18	16	21	19

in millions of $

Compound Annual Growth

	10y	5y	3y
Sales	—	—	—
Cash Flow	—	—	0.00%
Earnings	—	—	0.00%
Book Value	—	—	0.00%

Revenue

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’22	—	—	—	—	1
’21	0	0	0	0	1

in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

	Mar	Jun	Sep	Dec	Year
’26	(4)	(3)	(2)	—	—
’22	(6)	(4)	(3)	(15)	(28)
’21	(14)	(10)	(13)	(13)	(49)
’20	(6)	(11)	(12)	(15)	(44)

in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

	Mar	Jun	Sep	Dec	Year
’26	(4)	(3)	(2)	—	—
’22	(6)	(4)	(3)	(15)	(28)
’21	(14)	(10)	(13)	(13)	(49)
’20	(6)	(11)	(12)	(15)	(45)

in millions of $ · fiscal quarters ending in the months shown

EPS

	Mar	Jun	Sep	Dec	Year
’26	4.91	(1.51)	(0.30)	—	—
’22	(126.80)	(42.00)	(98.80)	(12.33)	(177.30)
’21	(377.62)	(293.71)	(279.72)	401.60	(405.60)
’20	(5.64k)	(2.41k)	867.13	1.46k	(5.50k)

fiscal quarters ending in the months shown

2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
—	—	—	—	—	—	4,998.08	1,358.02	296.94	1.55	Analyst estimates 2023–2025 Powerpack	Low Price
—	—	—	—	—	—	12,600.19	14,196.21	2,968.04	403.21		High Price
—	—	—	—	—	—	—	57	80	9		Employees
—	—	—	—	—	—	—	0	0	0		Revenue/Emp
—	—	—	—	—	—	—	0	1	1		Revenue
—	—	—	—	—	—	—	(251.32%)	(126.39%)	(452.32%)		Gross Margin
—	—	—	—	—	—	(33)	(76)	(20)	(59)		EBT
—	—	—	—	—	—	0.00%	(15,436.11%)	(1,830.46%)	(4,633.18%)		EBT Margin
—	—	—	—	—	—	(33)	(76)	(20)	(59)		Net Income
—	—	—	—	—	—	0	3	3	2		Depreciation
—	—	—	—	—	—	0.00	37.07	19.64	3.82		Revenue/Sh
—	—	—	—	—	—	(4,867.13)	(5,496.50)	(405.60)	(177.30)		Earnings/Sh
—	—	—	—	—	—	(7,469.25)	(3,312.63)	(895.82)	(83.71)		Cash Flow/Sh
—	—	—	—	—	—	(196.87)	(48.05)	(3.69)	(0.06)		Capex/Sh
—	—	—	—	—	—	(7,666.12)	(3,360.68)	(899.51)	(83.77)		Free CF/Sh
—	—	—	—	—	—	(2,495.67)	(1,112.71)	240.47	(73.02)		Book Value/Sh
—	—	—	—	—	—	0	0	0	0		Shares
—	—	—	—	—	—	—	0.00	0.00	0.00		PE Ratio
—	—	—	—	—	—	—	0.00	15.63	1.06		PS Ratio
—	—	—	—	—	—	—	0.00	1.28	0.00		PB Ratio
—	—	—	—	—	—	—	0.00	8.81	2.79		EV/Sales
—	—	—	—	—	—	—	0.05	(0.19)	(0.11)		EV/FCF
—	—	—	—	—	—	(50)	(44)	(49)	(28)		Op' Cash Flow
—	—	—	—	—	—	(1)	(1)	0	0		Capex
—	—	—	—	—	—	(51)	(45)	(49)	(28)		FCF
—	—	—	—	—	—	12	19	8	(15)		Working Cap'
—	—	—	—	—	—	—	9	9	7		Total Debt
—	—	—	—	—	—	(18)	(21)	(7)	2		Net Debt
—	—	—	—	—	—	(17)	(15)	13	(24)		Sh' Equity
—	—	—	—	—	—	0.00%	(123.79%)	(32.41%)	(185.74%)		ROA
—	—	—	—	—	—	0.00%	0.00%	(202.50%)	0.00%		ROIC
—	—	—	—	—	—	0.00%	482.87%	2,513.54%	1,067.45%		ROE

predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2022 · latest quarter Dec 2021